Trials / Sponsors / CINJRegulatory
CINJRegulatory
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | High-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma | Phase 2 | 2014-11-26 |